HALIFAX, Dec. 6 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,
NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions,
announced today that it has won an official government tender in the Republic
of Tatarsan with its Multiplo(TM) Rapid HBV/HIV/HCV Antibody Test (Multiplo
HBV/HIV/HCV). This success is the first in the Company's drive to penetrate
the government tender market in the Russian Federation and former CIS states
with its unique 3-in-1 test. This achievement is a direct result of the
ongoing efforts of its Russian distributor and the World Trade Center in
Koeln, Germany.
